When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council
- Simpson, E.L.
- Bruin-Weller, M. de
- Flohr, C.
- Ardern-Jones, M.R.
- Barbarot, S.
- Deleuran, M.
- Bieber, T.
- Vestergaard, C.
- Brown, S.J.
- Cork, M.J.
- Drucker, A.M.
- Eichenfield, L.F.
- Foelster-Holst, R.
- Guttman-Yassky, E.
- Nosbaum, A.
- Reynolds, N.J.
- Silverberg, J.I.
- Schmitt, J.
- Seyger, M.M.B.
- Spuls, P.I.
- Stalder, J.F.
- Su, J.C.
- Takaoka, R.
- Traidl-Hoffmann, C.
- Thyssen, J.P.
- Schaft, J. van der
- Wollenberg, A.
- Irvine, A.D.
- Paller, A.S.
DOIAbstract
Item does not contain fulltextBACKGROUND: Although most patients with atopic dermatitis (AD) are effectively managed with topical medication, a significant minority require systemic therapy. Guidelines for decision making about advancement to systemic therapy are lacking. OBJECTIVE: To guide those considering use of systemic therapy in AD and provide a framework for evaluation before making this therapeutic decision with the patient. METHODS: A subgroup of the International Eczema Council determined aspects to consider before prescribing systemic therapy. Topics were assigned to expert reviewers who performed a topic-specific literature review, referred to guidelines when available, and provided interpretation and expert opinion. RESULTS: W...
Add to ORKG